IE60901B1
(en)
*
|
1986-08-21 |
1994-08-24 |
Vestar Inc |
Improved treatment of systemic fungal infections with phospholipid particles encapsulating polyene antifungal antibiotics
|
US4783220A
(en)
*
|
1986-12-18 |
1988-11-08 |
Xerox Corporation |
Vesicle ink compositions
|
FR2634375B3
(fr)
*
|
1988-06-30 |
1991-07-05 |
Centre Nat Rech Scient |
Procede de preparation de systemes colloidaux dispersibles de lipide amphiphiles sous forme de liposomes submicroniques
|
US5023086A
(en)
*
|
1987-03-13 |
1991-06-11 |
Micro-Pak, Inc. |
Encapsulated ionophore growth factors
|
US5271881A
(en)
*
|
1987-09-28 |
1993-12-21 |
Redding Bruce K |
Apparatus and method for making microcapsules
|
WO1992011083A1
(en)
*
|
1987-09-28 |
1992-07-09 |
Redding Bruce K Jr |
Apparatus and method for making microcapsules
|
IL88076A
(en)
*
|
1987-10-28 |
1993-01-14 |
Nippon Shinyaku Co Ltd |
Fat emulsions as drug carriers
|
US5013497A
(en)
*
|
1988-03-03 |
1991-05-07 |
Micro-Pak, Inc. |
Method and apparatus for producing lipid vesicles
|
US4895452A
(en)
*
|
1988-03-03 |
1990-01-23 |
Micro-Pak, Inc. |
Method and apparatus for producing lipid vesicles
|
MX9203504A
(es)
*
|
1988-04-20 |
1992-07-01 |
Liposome Co Inc |
Complejo agente: lipido activo de alta proporcion.
|
EP0414806B1
(de)
*
|
1988-05-20 |
1994-07-20 |
The Liposome Company, Inc. |
Aktives mittel: lipid-komplex mit hohem verhältnis
|
US4935171A
(en)
*
|
1989-01-27 |
1990-06-19 |
Vestar, Inc. |
Method for vesicle formation
|
EP0469082B1
(de)
*
|
1989-04-18 |
1995-04-05 |
Vestar, Inc. |
Markierung mit liposomen von ischämischen geweben
|
FR2649335B1
(fr)
*
|
1989-07-05 |
1991-09-20 |
Texinfine Sa |
Procede et dispositif de production directe de liposomes
|
WO1991001367A1
(en)
*
|
1989-07-20 |
1991-02-07 |
Bioeng, Inc. |
Supercritical fluid disruption of and extraction from microbial cells
|
US5776429A
(en)
*
|
1989-12-22 |
1998-07-07 |
Imarx Pharmaceutical Corp. |
Method of preparing gas-filled microspheres using a lyophilized lipids
|
US5123414A
(en)
*
|
1989-12-22 |
1992-06-23 |
Unger Evan C |
Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
|
GB9000705D0
(en)
*
|
1990-01-12 |
1990-03-14 |
Royal Postgrad Med School |
Improvements in or relating to radiotherapeutic agents
|
US5820848A
(en)
*
|
1990-01-12 |
1998-10-13 |
The Liposome Company, Inc. |
Methods of preparing interdigitation-fusion liposomes and gels which encapsulate a bioactive agent
|
EP0562306B1
(de)
*
|
1992-03-06 |
1995-08-30 |
Zdzislaw Dr. Fiutowski |
Pharmazeutische Zusammensetzung mit antiviraler und antibakterieller Wirkung
|
ES2041597B1
(es)
*
|
1992-05-05 |
1994-06-01 |
Bazaco Joan Freixas |
Nuevo procedimiento para la preparacion de liposomas que encapsulan productos farmaceuticos y cosmeticos.
|
KR100315215B1
(ko)
*
|
1992-10-14 |
2002-06-20 |
질레스피 카롤 |
인터디지테이션-융합된리포좀과겔
|
AU3244393A
(en)
*
|
1992-12-02 |
1994-06-22 |
Vestar, Inc. |
Antibiotic formulation and process
|
US5958449A
(en)
|
1992-12-02 |
1999-09-28 |
Nexstar Pharmaceuticals, Inc. |
Antibiotic formulation and use for bacterial infections
|
US5650156A
(en)
*
|
1993-02-22 |
1997-07-22 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of nutriceuticals and compositions useful therefor
|
US6753006B1
(en)
|
1993-02-22 |
2004-06-22 |
American Bioscience, Inc. |
Paclitaxel-containing formulations
|
US5665382A
(en)
*
|
1993-02-22 |
1997-09-09 |
Vivorx Pharmaceuticals, Inc. |
Methods for the preparation of pharmaceutically active agents for in vivo delivery
|
US5916596A
(en)
*
|
1993-02-22 |
1999-06-29 |
Vivorx Pharmaceuticals, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
US6528067B1
(en)
|
1993-02-22 |
2003-03-04 |
American Bioscience, Inc. |
Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof
|
US5997904A
(en)
*
|
1993-02-22 |
1999-12-07 |
American Bioscience, Inc. |
Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof
|
AU673057B2
(en)
*
|
1993-02-22 |
1996-10-24 |
Abraxis Bioscience, Llc |
Methods for (in vivo) delivery of biologics and compositionsuseful therefor
|
US5439686A
(en)
*
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
US5759571A
(en)
*
|
1993-05-11 |
1998-06-02 |
Nexstar Pharmaceuticals, Inc. |
Antibiotic formulation and use for drug resistant infections
|
DE69407292T2
(de)
*
|
1993-06-30 |
1998-06-25 |
Genentech Inc |
Verfahren zur herstellung von liposomen
|
WO1995003035A1
(en)
*
|
1993-07-23 |
1995-02-02 |
Massachusetts Institute Of Technology |
Polymerized liposomes with enhanced stability for oral delivery
|
US6004534A
(en)
*
|
1993-07-23 |
1999-12-21 |
Massachusetts Institute Of Technology |
Targeted polymerized liposomes for improved drug delivery
|
NZ275054A
(en)
*
|
1993-11-08 |
1997-04-24 |
Peptide Delivery Systems Pty L |
Diagnosing atherosclerosis or coronary artery disease using labelled composition which mimics essential features of an exogenous lipoprotein
|
US5468499A
(en)
*
|
1993-11-15 |
1995-11-21 |
Ohio State University |
Liposomes containing the salt of phosphoramide mustard and related compounds
|
US5589189A
(en)
*
|
1994-09-14 |
1996-12-31 |
Nexstar Pharmaceuticals, Inc. |
Liposome dispersion
|
US5662929A
(en)
*
|
1994-12-23 |
1997-09-02 |
Universite De Montreal |
Therapeutic liposomal formulation
|
ATE452136T1
(de)
|
1995-05-04 |
2010-01-15 |
Gilead Sciences Inc |
Nukleinsäureligand-komplexe
|
DE19639811A1
(de)
*
|
1996-09-27 |
1998-04-02 |
Artur Herzog Dr Mesmer |
Verwendung einer Liposomenlösung zur Verstärkung der Wirksamkeit und/oder Verminderung der Toxizität von Arzneimitteln
|
US6060082A
(en)
|
1997-04-18 |
2000-05-09 |
Massachusetts Institute Of Technology |
Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
|
AUPP032097A0
(en)
*
|
1997-11-11 |
1997-12-04 |
Peptide Delivery Systems Pty Ltd |
Improved labelled diagnostic compositions and methods of their use
|
US20010003580A1
(en)
|
1998-01-14 |
2001-06-14 |
Poh K. Hui |
Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
|
US6727079B1
(en)
*
|
1998-02-25 |
2004-04-27 |
The United States Of America As Represented By The Department Of Health And Human Services |
cDNA encoding a gene BOG (B5T Over-expressed Gene) and its protein product
|
US6171652B1
(en)
*
|
1998-05-26 |
2001-01-09 |
Brij P. Singh |
Method for modifying surfaces with ultra thin films
|
US6613352B2
(en)
|
1999-04-13 |
2003-09-02 |
Universite De Montreal |
Low-rigidity liposomal formulation
|
CA2399229A1
(en)
*
|
2000-01-31 |
2001-08-02 |
Collaborative Technologies, Inc. |
Surfactant free topical compositions and method for rapid preparation thereof
|
US6992081B2
(en)
|
2000-03-23 |
2006-01-31 |
Elan Pharmaceuticals, Inc. |
Compounds to treat Alzheimer's disease
|
AU2001252958A1
(en)
|
2000-03-23 |
2001-10-03 |
Elan Pharmaceuticals, Inc. |
Compounds and methods to treat alzheimer's disease
|
NZ522842A
(en)
*
|
2000-06-09 |
2004-11-26 |
Osi Pharm Inc |
Liposomal benzoquinazoline thymidylate synthase inhibitor formulations
|
MXPA02012560A
(es)
*
|
2000-06-30 |
2003-05-14 |
Elan Pharm Inc |
Compuestos para tratar la enfermedad de alzheimer.
|
PE20020276A1
(es)
|
2000-06-30 |
2002-04-06 |
Elan Pharm Inc |
COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER
|
US6846813B2
(en)
|
2000-06-30 |
2005-01-25 |
Pharmacia & Upjohn Company |
Compounds to treat alzheimer's disease
|
US20030096864A1
(en)
*
|
2000-06-30 |
2003-05-22 |
Fang Lawrence Y. |
Compounds to treat alzheimer's disease
|
US20020150566A1
(en)
*
|
2001-03-23 |
2002-10-17 |
Kun-Liang Guan |
Method of inhibiting cancerous cell proliferation using Ras mutants of GDP-bound conformation
|
US6984395B2
(en)
*
|
2001-04-11 |
2006-01-10 |
Qlt, Inc. |
Drug delivery system for hydrophobic drugs
|
EP1401452A1
(de)
*
|
2001-06-27 |
2004-03-31 |
Elan Pharmaceuticals, Inc. |
Beta-hydroxyamin-derivate zur behandlung von alzheimer krankheit
|
EA200200925A1
(ru)
*
|
2002-07-18 |
2003-04-24 |
Ооо "Био-3" |
Способ получения вододисперсионных препаратов жирорастворимых витаминов и антиоксидантов
|
CA2506746A1
(en)
*
|
2002-11-26 |
2004-06-10 |
Gilead Sciences, Inc. |
Method of drug loading in liposomes by gradient
|
US9944713B2
(en)
|
2004-11-24 |
2018-04-17 |
Medicinal Bioconvergence Research Center |
Antibody specific to the AIMP2-DX2
|
US7459529B2
(en)
|
2004-11-24 |
2008-12-02 |
Seoul National University Industry Foundation |
AIMP2-DX2 and its uses
|
US20080045575A1
(en)
*
|
2004-12-29 |
2008-02-21 |
Van Dyke Thomas E |
Delivery of H2 Antagonists
|
EP2010117A4
(de)
*
|
2006-04-12 |
2010-12-01 |
Massachusetts Inst Technology |
Zusammensetzungen und verfahren zur adhäsionshemmung
|
EP3115060A1
(de)
|
2008-04-18 |
2017-01-11 |
VaxInnate Corporation |
Flagellin deletionsmutanten und deren verwendung
|
US9226984B2
(en)
*
|
2010-12-14 |
2016-01-05 |
Technical University of Denmark and Rigshospitalet |
Entrapment of radionuclides in nanoparticle compositions
|
WO2012138867A2
(en)
|
2011-04-07 |
2012-10-11 |
The Board Of Trustees Of The Leland Stanford Junior University |
Long-acting peptide analogs
|
GB201204384D0
(en)
|
2012-03-13 |
2012-04-25 |
Univ Dundee |
Anti-flammatory agents
|
AU2013360302C1
(en)
|
2012-12-12 |
2019-01-24 |
Temple University - Of The Commonwealth System Of Higher Education |
Compositions and methods for treatment of cancer
|
KR101638156B1
(ko)
|
2013-10-29 |
2016-07-08 |
가톨릭대학교 산학협력단 |
C형 간염 바이러스 감염 질환의 예방 또는 치료용 약학 조성물
|
CA2970795A1
(en)
|
2014-12-18 |
2016-06-23 |
Alnylam Pharmaceuticals, Inc. |
Reversir compounds
|
DK3615545T3
(da)
|
2017-04-24 |
2021-11-22 |
Cocrystal Pharma Inc |
Pyrrolopyrimidinderivativer, der er nyttige som hæmmere af replikation af influenzavirus
|
JP2021532149A
(ja)
|
2018-07-27 |
2021-11-25 |
コクリスタル ファーマ, インコーポレイテッドCocrystal Pharma, Inc. |
インフルエンザウイルス複製阻害剤としてのピロロ[2,3−b]ピリジン誘導体
|
ES2937837T3
(es)
|
2018-09-10 |
2023-03-31 |
Cocrystal Pharma Inc |
Inhibidores de piridopirazina y piridotriazina de la replicación del virus de la gripe
|
BR112021007275A2
(pt)
|
2018-10-17 |
2021-07-20 |
Cocrystal Pharma, Inc. |
combinações de inibidores de replicação de vírus da influenza
|
WO2020112716A1
(en)
|
2018-11-26 |
2020-06-04 |
Cocrystal Pharma, Inc. |
Inhibitors of influenza virus replication
|
WO2021188620A1
(en)
|
2020-03-17 |
2021-09-23 |
Cocrystal Pharma Inc. |
Peptidomimetic n5-methyl-n2-(nonanoyl-l-leucyl)-l-glutaminate derivatives, triazaspiro[4.14]nonadecane derivatives and similar compounds as inhibitors of norovirus and coronavirus replication
|
KR20230008079A
(ko)
|
2020-04-10 |
2023-01-13 |
코크리스탈 파마, 아이엔씨. |
노로바이러스 및 코로나바이러스 복제 억제제
|
IL310394A
(en)
|
2021-08-03 |
2024-03-01 |
Cocrystal Pharma Inc |
Corona virus inhibitors
|